Laboratory of Genetics, School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Structural Biology Unit, CIC bioGUNE, Derio, Bizkaia, Spain.
mSphere. 2019 Sep 25;4(5):e00554-19. doi: 10.1128/mSphere.00554-19.
Dityromycin is a peptide antibiotic isolated from the culture broth of the soil microorganism sp. strain AM-2504. Recent structural studies have shown that dityromycin targets the ribosomal protein S12 in the 30S ribosomal subunit, inhibiting translocation. Herein, by using protein synthesis assays, we identified the resistance mechanism of the producer strain to the secondary metabolite dityromycin. The results show that the self-resistance mechanism of the sp. strain AM-2504 is due to a specific modification of the ribosome. In particular, two amino acid substitutions, located in a highly conserved region of the S12 protein corresponding to the binding site of the antibiotic, were found. These mutations cause a substantial loss of affinity of the dityromycin for the 30S ribosomal subunit, protecting the producer strain from the toxic effect of the antibiotic. In addition to providing a detailed description of the first mechanism of self-resistance based on a mutated ribosomal protein, this work demonstrates that the molecular determinants of the dityromycin resistance identified in can be transferred to ribosomes, where they can trigger the same antibiotic resistance mechanism found in the producer strain. The World Health Organization has identified antimicrobial resistance as a substantial threat to human health. Because of the emergence of pathogenic bacteria resistant to multiple antibiotics worldwide, there is a need to identify the mode of action of antibiotics and to unravel the basic mechanisms responsible for drug resistance. Antibiotic producers' microorganisms can protect themselves from the toxic effect of the drug using different strategies; one of the most common involves the modification of the antibiotic's target site. In this work, we report a detailed analysis of the molecular mechanism, based on protein modification, devised by the soil microorganism sp. strain AM-2504 to protect itself from the activity of the peptide antibiotic dityromycin. Furthermore, we demonstrate that this mechanism can be reproduced in , thereby eliciting antibiotic resistance in this human commensal bacterium.
地衣霉素是一种从土壤微生物 sp. 菌株 AM-2504 的发酵液中分离得到的肽类抗生素。最近的结构研究表明,地衣霉素靶向核糖体蛋白 S12 在 30S 核糖体亚基中,抑制易位。在此,我们通过使用蛋白质合成测定法,鉴定了产生菌对次级代谢产物地衣霉素的抗性机制。结果表明,sp. 菌株 AM-2504 的自身抗性机制是由于核糖体的特异性修饰。特别是,在抗生素结合位点对应的 S12 蛋白的高度保守区域发现了两个氨基酸取代。这些突变导致地衣霉素与 30S 核糖体亚基的亲和力大大丧失,从而保护产生菌免受抗生素的毒性作用。除了详细描述基于突变核糖体蛋白的第一个自身抗性机制外,这项工作还表明,在 中鉴定的地衣霉素抗性的分子决定因素可以转移到 核糖体上,在那里它们可以触发在产生菌中发现的相同的抗生素抗性机制。世界卫生组织已将抗微生物药物耐药性确认为对人类健康的重大威胁。由于世界各地出现了对多种抗生素具有耐药性的致病细菌,因此需要确定抗生素的作用模式,并揭示导致耐药性的基本机制。抗生素产生菌的微生物可以使用不同的策略来保护自己免受药物的毒性作用;其中最常见的一种涉及抗生素靶位的修饰。在这项工作中,我们基于 sp. 菌株 AM-2504 设计的基于蛋白质修饰的分子机制进行了详细分析,以保护自己免受肽类抗生素地衣霉素的活性。此外,我们证明该机制可以在 中重现,从而在这种人类共生菌中引起抗生素耐药性。